Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the donor’s immune cells attack the recipient’s tissues.
Novel MSC-based therapy provides hope for ocular GVHD treatment
- Post author:admin
- Post published:February 10, 2025
- Post category:uncategorized
- Post comments:0 Comments